Abstract

We read the interesting paper by Dr. Zaiss and colleagues ([1][1]) on the role of regulatory T cells (Treg cells) in local and systemic bone destruction in arthritis. We suggest that effective targeting of Treg cells makes CD28 superagonist Abs (CD28 SA) a promising novel reagent to prevent

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.